Wayfinder Biosciences
Wayfinder Biosciences: Engineering RNA for molecular detection and drug discovery since 2021.
Founded
2021Wayfinder Biosciences: Engineering RNA for molecular detection and drug discovery since 2021.
Wayfinder Biosciences, founded in 2021 and headquartered in San Francisco, CA, and Seattle, WA, focuses on engineering RNA for molecular detection and drug discovery. The company leverages proprietary computational design algorithms to create RNA switches that respond to specific chemicals and biomolecules. Their core mission is to target RNA as a solution to undruggable targets, aiming to eliminate disease-causing proteins before they are produced. Wayfinder's innovative approach addresses a significant challenge in cell biology and therapeutic development.
Notable affiliated individuals include leading scientists and biotech entrepreneurs who drive the company's vision forward. Investors comprise prominent venture capital firms specializing in biotech innovations. Key achievements include the successful development of a robust pipeline of small molecules targeting RNA, positioning Wayfinder as a pioneer in RNA-based therapeutics. The company's impact is significant, offering new solutions for diseases previously deemed undruggable, thus advancing the field of molecular medicine.
Companies similar to Wayfinder Biosciences include Aptah, Nymirum, Airna and Ribometrix.
Wayfinder Biosciences was founded in 2021.
Wayfinder Biosciences' headquarters is located in San Francisco, CA, US.
Wayfinder Biosciences' most recent funding round was for $500k (USD) in December 2022.
As of Dec 5, 2022, Wayfinder Biosciences has disclosed funding of $4.3M (USD). Undisclosed round amounts are excluded.
Wayfinder Biosciences has 5 employees as of Feb 4, 2024.
ribometrix.com
